Concepedia

Publication | Closed Access

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

DOI

590

Citations

22

References

2008

Year

Robert D. Inman, John C. Davis, Désirée van der Heijde, Laura Diekman, Joachim Sieper, Sung Il Kim, M. Mack, John Han, Sudha Visvanathan, Zhenhua Xu,
Arthritis & Rheumatism

Abstract

Golimumab was effective and well tolerated in a large cohort of patients with AS during a 24-week study period.

References

YearCitations

Page 1